Kairos Pharma
Price & Volume
Stats
See more52W Range | $1.51-$9.59 |
Market Cap | $5.8M |
Shares Short | 114,388 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.96 |
News
See moreYahoo Finance • 2 months ago
Bayer (XTRA:BAYN) Stock Still Looks Reasonable On New Prostate Cancer News
Yahoo Finance • 2 months ago
Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer
Yahoo Finance • 2 months ago
Kairos Pharma Reports Breakthrough Interim Safety Data in Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer Patients — Targeting a $10 Billion Drug Resistance Market
Yahoo Finance • 5 months ago
KAPA Investors Have Opportunity to Join Kairos Pharma, Ltd. Fraud Investigation with the Schall Law Firm
About
CEO | Dr. John S. Yu M.D., Ph.D. |
Address | 2355 Westwood Blvd., Los Angeles, CA, United States, 90064 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1 |